ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Phosphorylation-Facilitated CKB Lactylation At K11 By GCN5 Enhances Creatine Kinase Activity and Mitigates Neuronal Damage After Cerebral Ischemia-Reperfusion.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Ischemia-reperfusion (I/R) injury in stroke causes severe neuronal damage through oxidative stress and metabolic dysfunction. Beyond its metabolic role, lactate can induce lysine lactylation, but its impact on neuroprotection remains unclear. Here, we employed integrative proteomic, lactylomic, and phosphoproteomic profiling in a murine I/R model and identified creatine kinase B-type (CKB) as a dual target of K11 lactylation and S199 phosphorylation. These modifications were found to enhance CKB enzymatic activity, promote phosphocreatine metabolism, suppress reactive oxygen species, and support neuronal survival under ischemic conditions. Mechanistically, the acetyltransferase GCN5 catalyzed K11 lactylation, while Sirt5 functioned as a delactylase. Notably, S199 phosphorylation facilitated K11 lactylation by promoting GCN5 recruitment, suggesting a hierarchical interplay between the two modifications. In vivo studies confirmed that disruption of either K11 lactylation or S199 phosphorylation impaired CKB function, exacerbated neuronal injury, and delayed functional recovery after stroke. These findings reveal a coordinated post-translational modification mechanism that enhances CKB activity and confers neuroprotection in cerebral I/R injury, offering a potential therapeutic target for stroke intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.